(Reuters) - Pfizer Inc on Wednesday filed a lawsuit against Johnson & Johnson , saying that the drugmaker's anticompetitive contracts with health insurers prevented biosimilar competition to its blockbuster rheumatoid arthritis drug, Remicade.